In last trading session, Co-Diagnostics Inc. (NASDAQ:CODX) saw 0.52 million shares changing hands with its beta currently measuring -1.95. Company’s recent per share price level of $10.58 trading at -$0.1 or -0.94% at ring of the bell on the day assigns it a market valuation of $316.66M. That closing price of CODX’s stock is at a discount of -95.56% from its 52-week high price of $20.69 and is indicating a premium of 33.74% from its 52-week low price of $7.01. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.65 million shares which gives us an average trading volume of 1.29 million if we extend that period to 3-months.
For Co-Diagnostics Inc. (CODX), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 2.30. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $0.22 in the current quarter.
3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Upright in the red during last session for losing -0.94%, in the last five days CODX remained trading in the red while hitting it’s week-highest on Tuesday, 09/07/21 when the stock touched $10.58 price level, adding 5.54% to its value on the day. Co-Diagnostics Inc.’s shares saw a change of 13.76% in year-to-date performance and have moved -4.94% in past 5-day. Co-Diagnostics Inc. (NASDAQ:CODX) showed a performance of 10.79% in past 30-days. Number of shares sold short was 3.02 million shares which calculate 1.94 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $23.00 to the stock, which implies a rise of 54.0% to its current value. Analysts have been projecting $16.00 as a low price target for the stock while placing it at a high target of $30.00. It follows that stock’s current price would drop -183.55% in reaching the projected high whereas dropping to the targeted low would mean a loss of -51.23% for stock’s current value.
Co-Diagnostics Inc. (CODX) estimates and forecasts
Statistics highlight that Co-Diagnostics Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -24.10% of value to its shares in past 6 months, showing an annual growth rate of -37.50% while that of industry is 18.60. Apart from that, the company came lowering its revenue forecast for fiscal year 2021. The company is estimating its revenue growth to decrease by -48.80% in the current quarter and calculating -60.40% decrease in the next quarter. This year revenue growth is estimated to rise 27.70% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $27.36 million for the same. And 3 analysts are in estimates of company making revenue of $24.32 million in the next quarter that will end on Sep 2021.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 55.00% during past 5 years.
Co-Diagnostics Inc. is more likely to be releasing its next quarterly report between November 15 and November 19 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Co-Diagnostics Inc. (NASDAQ:CODX)’s Major holders
Insiders are in possession of 6.15% of company’s total shares while institution are holding 25.41 percent of that, with stock having share float percentage of 27.08%. Investors also watch the number of corporate investors in a company very closely, which is 25.41% institutions for Co-Diagnostics Inc. that are currently holding shares of the company. Vanguard Group, Inc. (The) is the top institutional holder at CODX for having 1.85 million shares of worth $15.25 million. And as of Jun 29, 2021, it was holding 6.40% of the company’s outstanding shares.
The second largest institutional holder is Blackrock Inc., which was holding about 0.52 million shares on Jun 29, 2021. The number of shares represents firm’s hold over 1.79% of outstanding shares, having a total worth of $4.27 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 30, 2021, the former fund manager was holding 0.8 million shares of worth $7.63 million or 2.77% of the total outstanding shares. The later fund manager was in possession of 0.36 million shares on Mar 30, 2021, making its stake of worth around $3.47 million in the company or a holder of 1.26% of company’s stock.